Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

Winter and family holiday gatherings often bring a surge in a wide variety of respiratory issues. Here's what to watch for.

Zuo is a public health resident at the University of British Columbia who works with Northern Health’s medical health ...

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

(HealthDay News) — COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents early in the 2024 to 2025 season, according to research published ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

FluMist, a self-administered flu vaccine, is approved for ages 2-49, but will be available in the 2025-2026 season. RSV vaccination is vital for older adults, with new guidelines for those aged 60-74, ...

Some hospitals in the U.S. are seeing an increase in cases of RSV and so-called "walking pneumonia." Here's what you need to ...

The NHS says the RSV vaccine is recommended from 28 weeks of pregnancy, to protect the baby for the first few months after ...